Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation: the NCT Neuro Master Match (N2M2) pilot study
AbstractBackground. O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status is a predictive biomarker in glioblastoma patients. Glioblastoma
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2018
|
| In: |
Neuro-Oncology
Year: 2017, Volume: 20, Issue: 6, Pages: 826-837 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/nox216 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1093/neuonc/nox216 Verlag, Volltext: https://academic.oup.com/neuro-oncology/article/20/6/826/4641653 
|
| Author Notes: | Elke Pfaff, Tobias Kessler, Gnana Prakash Balasubramanian, Anne Berberich, Daniel Schrimpf, Antje Wick, Jürgen Debus, Andreas Unterberg, Martin Bendszus, Christel Herold-Mende, David Capper, Irini Schenkel, Andreas Eisenmenger, Susan Dettmer, Benedikt Brors, Michael Platten, Stefan M. Pfister, Andreas von Deimling, David T.W. Jones, Wolfgang Wick, and Felix Sahm |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1580337597 | ||
| 003 | DE-627 | ||
| 005 | 20220814231709.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180823r20182017xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/neuonc/nox216 |2 doi | |
| 035 | |a (DE-627)1580337597 | ||
| 035 | |a (DE-576)510337597 | ||
| 035 | |a (DE-599)BSZ510337597 | ||
| 035 | |a (OCoLC)1341017369 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pfaff, Elke |d 1985- |e VerfasserIn |0 (DE-588)1037262174 |0 (DE-627)755739728 |0 (DE-576)39127614X |4 aut | |
| 245 | 1 | 0 | |a Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation |b the NCT Neuro Master Match (N2M2) pilot study |c Elke Pfaff, Tobias Kessler, Gnana Prakash Balasubramanian, Anne Berberich, Daniel Schrimpf, Antje Wick, Jürgen Debus, Andreas Unterberg, Martin Bendszus, Christel Herold-Mende, David Capper, Irini Schenkel, Andreas Eisenmenger, Susan Dettmer, Benedikt Brors, Michael Platten, Stefan M. Pfister, Andreas von Deimling, David T.W. Jones, Wolfgang Wick, and Felix Sahm |
| 264 | 1 | |c 2018 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.08.2018 | ||
| 500 | |a Published: 18 November 2017 | ||
| 520 | |a AbstractBackground. O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status is a predictive biomarker in glioblastoma patients. Glioblastoma | ||
| 534 | |c 2017 | ||
| 700 | 1 | |a Keßler, Tobias |d 1987- |e VerfasserIn |0 (DE-588)1104151693 |0 (DE-627)86164591X |0 (DE-576)470840277 |4 aut | |
| 700 | 1 | |a Balasubramanian, Gnana Prakash |d 1981- |e VerfasserIn |0 (DE-588)14362671X |0 (DE-627)647708922 |0 (DE-576)338051554 |4 aut | |
| 700 | 1 | |a Berberich, Anne |d 1988- |e VerfasserIn |0 (DE-588)1034064096 |0 (DE-627)743980654 |0 (DE-576)381718697 |4 aut | |
| 700 | 1 | |a Schrimpf, Daniel |d 1984- |e VerfasserIn |0 (DE-588)1063355044 |0 (DE-627)812332032 |0 (DE-576)422629529 |4 aut | |
| 700 | 1 | |a Wick, Antje |d 1972- |e VerfasserIn |0 (DE-588)122759869 |0 (DE-627)706032101 |0 (DE-576)293409609 |4 aut | |
| 700 | 1 | |a Debus, Jürgen |d 1964- |e VerfasserIn |0 (DE-588)1022671421 |0 (DE-627)717025780 |0 (DE-576)365774944 |4 aut | |
| 700 | 1 | |a Unterberg, Andreas |e VerfasserIn |0 (DE-588)1032681187 |0 (DE-627)738641200 |0 (DE-576)168441233 |4 aut | |
| 700 | 1 | |a Bendszus, Martin |e VerfasserIn |0 (DE-588)1032676426 |0 (DE-627)738634131 |0 (DE-576)175567697 |4 aut | |
| 700 | 1 | |a Herold-Mende, Christel |e VerfasserIn |0 (DE-588)1022936549 |0 (DE-627)717335577 |0 (DE-576)366194267 |4 aut | |
| 700 | 1 | |a Eisenmenger, Andreas |e VerfasserIn |0 (DE-588)1114766054 |0 (DE-627)869048333 |0 (DE-576)477499805 |4 aut | |
| 700 | 1 | |a Dettmer, Susan |e VerfasserIn |0 (DE-588)1136889507 |0 (DE-627)893684899 |0 (DE-576)49091263X |4 aut | |
| 700 | 1 | |a Brors, Benedikt |e VerfasserIn |0 (DE-588)1112102965 |0 (DE-627)866068732 |0 (DE-576)476376157 |4 aut | |
| 700 | 1 | |a Platten, Michael |d 1971- |e VerfasserIn |0 (DE-588)121627780 |0 (DE-627)081431848 |0 (DE-576)261969811 |4 aut | |
| 700 | 1 | |a Pfister, Stefan |d 1974- |e VerfasserIn |0 (DE-588)123850215 |0 (DE-627)706450930 |0 (DE-576)293908400 |4 aut | |
| 700 | 1 | |a Deimling, Andreas von |d 1959- |e VerfasserIn |0 (DE-588)103034115X |0 (DE-627)735093946 |0 (DE-576)378138065 |4 aut | |
| 700 | 1 | |a Jones, David T. W. |e VerfasserIn |0 (DE-588)1058669672 |0 (DE-627)79739334X |0 (DE-576)414823583 |4 aut | |
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 700 | 1 | |a Sahm, Felix |d 1984- |e VerfasserIn |0 (DE-588)1022852132 |0 (DE-627)717318478 |0 (DE-576)366075020 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuro-Oncology |d Oxford : Oxford Univ. Press, 1999 |g 20(2018), 6, Seite 826-837 |h Online-Ressource |w (DE-627)357167341 |w (DE-600)2094060-9 |w (DE-576)318041839 |x 1523-5866 |7 nnas |a Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation the NCT Neuro Master Match (N2M2) pilot study |
| 773 | 1 | 8 | |g volume:20 |g year:2018 |g number:6 |g pages:826-837 |g extent:12 |a Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation the NCT Neuro Master Match (N2M2) pilot study |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/neuonc/nox216 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/neuro-oncology/article/20/6/826/4641653 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200326 | ||
| 992 | |a 20180823 | ||
| 993 | |a Article | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 994 | |a 2018 | ||
| 998 | |g 1022852132 |a Sahm, Felix |m 1022852132:Sahm, Felix |d 910000 |d 912000 |e 910000PS1022852132 |e 912000PS1022852132 |k 0/910000/ |k 1/910000/912000/ |p 21 |y j | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 20 | ||
| 998 | |g 1058669672 |a Jones, David T. W. |m 1058669672:Jones, David T. W. |d 50000 |e 50000PJ1058669672 |k 0/50000/ |p 19 | ||
| 998 | |g 103034115X |a Deimling, Andreas von |m 103034115X:Deimling, Andreas von |d 910000 |d 912000 |e 910000PD103034115X |e 912000PD103034115X |k 0/910000/ |k 1/910000/912000/ |p 18 | ||
| 998 | |g 123850215 |a Pfister, Stefan |m 123850215:Pfister, Stefan |d 910000 |d 910500 |e 910000PP123850215 |e 910500PP123850215 |k 0/910000/ |k 1/910000/910500/ |p 17 | ||
| 998 | |g 121627780 |a Platten, Michael |m 121627780:Platten, Michael |d 60000 |d 62700 |e 60000PP121627780 |e 62700PP121627780 |k 0/60000/ |k 1/60000/62700/ |p 16 | ||
| 998 | |g 1112102965 |a Brors, Benedikt |m 1112102965:Brors, Benedikt |d 140000 |e 140000PB1112102965 |k 0/140000/ |p 15 | ||
| 998 | |g 1136889507 |a Dettmer, Susan |m 1136889507:Dettmer, Susan |d 910000 |e 910000PD1136889507 |k 0/910000/ |p 14 | ||
| 998 | |g 1114766054 |a Eisenmenger, Andreas |m 1114766054:Eisenmenger, Andreas |d 910000 |e 910000PE1114766054 |k 0/910000/ |p 13 | ||
| 998 | |g 1022936549 |a Herold-Mende, Christel |m 1022936549:Herold-Mende, Christel |d 910000 |d 911200 |e 910000PH1022936549 |e 911200PH1022936549 |k 0/910000/ |k 1/910000/911200/ |p 10 | ||
| 998 | |g 1032676426 |a Bendszus, Martin |m 1032676426:Bendszus, Martin |d 910000 |d 911100 |e 910000PB1032676426 |e 911100PB1032676426 |k 0/910000/ |k 1/910000/911100/ |p 9 | ||
| 998 | |g 1032681187 |a Unterberg, Andreas |m 1032681187:Unterberg, Andreas |d 910000 |d 911200 |e 910000PU1032681187 |e 911200PU1032681187 |k 0/910000/ |k 1/910000/911200/ |p 8 | ||
| 998 | |g 1022671421 |a Debus, Jürgen |m 1022671421:Debus, Jürgen |d 910000 |d 911400 |e 910000PD1022671421 |e 911400PD1022671421 |k 0/910000/ |k 1/910000/911400/ |p 7 | ||
| 998 | |g 122759869 |a Wick, Antje |m 122759869:Wick, Antje |d 910000 |d 911100 |e 910000PW122759869 |e 911100PW122759869 |k 0/910000/ |k 1/910000/911100/ |p 6 | ||
| 998 | |g 1063355044 |a Schrimpf, Daniel |m 1063355044:Schrimpf, Daniel |d 910000 |d 912000 |e 910000PS1063355044 |e 912000PS1063355044 |k 0/910000/ |k 1/910000/912000/ |p 5 | ||
| 998 | |g 1034064096 |a Berberich, Anne |m 1034064096:Berberich, Anne |d 910000 |d 911100 |e 910000PB1034064096 |e 911100PB1034064096 |k 0/910000/ |k 1/910000/911100/ |p 4 | ||
| 998 | |g 14362671X |a Balasubramanian, Gnana Prakash |m 14362671X:Balasubramanian, Gnana Prakash |d 910000 |e 910000PB14362671X |k 0/910000/ |p 3 | ||
| 998 | |g 1104151693 |a Keßler, Tobias |m 1104151693:Keßler, Tobias |d 910000 |d 911100 |e 910000PK1104151693 |e 911100PK1104151693 |k 0/910000/ |k 1/910000/911100/ |p 2 | ||
| 998 | |g 1037262174 |a Pfaff, Elke |m 1037262174:Pfaff, Elke |d 910000 |d 910500 |e 910000PP1037262174 |e 910500PP1037262174 |k 0/910000/ |k 1/910000/910500/ |p 1 |x j | ||
| 999 | |a KXP-PPN1580337597 |e 3613935716 | ||
| 999 | |a KXP-PPN1580337597 |e 3023022526 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1580337597"],"doi":["10.1093/neuonc/nox216"]},"name":{"displayForm":["Elke Pfaff, Tobias Kessler, Gnana Prakash Balasubramanian, Anne Berberich, Daniel Schrimpf, Antje Wick, Jürgen Debus, Andreas Unterberg, Martin Bendszus, Christel Herold-Mende, David Capper, Irini Schenkel, Andreas Eisenmenger, Susan Dettmer, Benedikt Brors, Michael Platten, Stefan M. Pfister, Andreas von Deimling, David T.W. Jones, Wolfgang Wick, and Felix Sahm"]},"recId":"1580337597","physDesc":[{"extent":"12 S."}],"title":[{"subtitle":"the NCT Neuro Master Match (N2M2) pilot study","title":"Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation","title_sort":"Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation"}],"note":["Gesehen am 23.08.2018"," Published: 18 November 2017"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"person":[{"display":"Pfaff, Elke","role":"aut","given":"Elke","family":"Pfaff"},{"display":"Keßler, Tobias","family":"Keßler","given":"Tobias","role":"aut"},{"role":"aut","given":"Gnana Prakash","family":"Balasubramanian","display":"Balasubramanian, Gnana Prakash"},{"given":"Anne","role":"aut","family":"Berberich","display":"Berberich, Anne"},{"display":"Schrimpf, Daniel","family":"Schrimpf","given":"Daniel","role":"aut"},{"display":"Wick, Antje","family":"Wick","role":"aut","given":"Antje"},{"display":"Debus, Jürgen","family":"Debus","given":"Jürgen","role":"aut"},{"given":"Andreas","role":"aut","family":"Unterberg","display":"Unterberg, Andreas"},{"given":"Martin","role":"aut","family":"Bendszus","display":"Bendszus, Martin"},{"display":"Herold-Mende, Christel","family":"Herold-Mende","role":"aut","given":"Christel"},{"family":"Eisenmenger","role":"aut","given":"Andreas","display":"Eisenmenger, Andreas"},{"family":"Dettmer","role":"aut","given":"Susan","display":"Dettmer, Susan"},{"family":"Brors","given":"Benedikt","role":"aut","display":"Brors, Benedikt"},{"family":"Platten","role":"aut","given":"Michael","display":"Platten, Michael"},{"family":"Pfister","given":"Stefan","role":"aut","display":"Pfister, Stefan"},{"given":"Andreas von","role":"aut","family":"Deimling","display":"Deimling, Andreas von"},{"display":"Jones, David T. W.","role":"aut","given":"David T. W.","family":"Jones"},{"display":"Wick, Wolfgang","family":"Wick","role":"aut","given":"Wolfgang"},{"role":"aut","given":"Felix","family":"Sahm","display":"Sahm, Felix"}],"relHost":[{"disp":"Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation the NCT Neuro Master Match (N2M2) pilot studyNeuro-Oncology","physDesc":[{"extent":"Online-Ressource"}],"recId":"357167341","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 21.07.23"],"id":{"zdb":["2094060-9"],"eki":["357167341"],"issn":["1523-5866"]},"title":[{"title":"Neuro-Oncology","title_sort":"Neuro-Oncology","subtitle":"official journal of the World Federation of Neuro-Oncology"}],"part":{"issue":"6","text":"20(2018), 6, Seite 826-837","extent":"12","pages":"826-837","volume":"20","year":"2018"},"origin":[{"dateIssuedDisp":"1999-","dateIssuedKey":"1999","publisherPlace":"Oxford ; Durham, NC","publisher":"Oxford Univ. Press ; Duke University Medical Center"}],"pubHistory":["1.1999 -"]}],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}]} | ||
| SRT | |a PFAFFELKEKFEASIBILIT2018 | ||